Revolutionizing Cancer Treatment
APAC Biotech is a biotechnology company focused on the research and development of dendritic cell based personalised immunotherapies for cancer treatment. With more than a decade of research, our versatile team of scientists and doctors are going deeper into creating unmatched customized cancer therapeutics to enhance the immune system further, enabling it to fight cancer better.
- ABOUT
APAC Biotech & Immunotherapy
APAC Biotech is an Indian biotechnology company involved in research and development of advanced personalised cancer immunotherapies since 2009. The company's dendritic cell based personalised immunotherapy, APCEDEN®, is the first of its kind immunotherapy recognised and approved by the Indian Health Regulatory.
- Advanced Immunotherapy
Specializes in personalized dendritic cell-based immunotherapy to enhance the immune system’s ability to fight cancer.
- Decade of Research
Over ten years of cutting-edge research to provide innovative treatments with reduced side effects.
- TECHNOLOGY
Advanced Cancer Therapy Technology
APCEDEN®
APCEDEN®, aims at enabling the patient’s immune system to recognise these tumor cells and destroy them. Because of the immune system's unique properties, these therapies may hold greater potential
LTR-Memvaxraleucel™
The vaccine technology works by “tricking” the immune system into treating cancer as it would a viral infection through the reprogramming of powerful immune cells known as dendritic cells.
- PROCESS
Our Immunotherapy Process
1
Tumor Cell Collection
Cancer Patient first undergoes surgery or biopsy at the hospital for collecting fresh tumor tissue. The tumor tissue is collected and stored in special Tissue Transport Medium supplied by APAC Biotech.
2
Leukapheresis Collection
Patient also undergoes a Leukapharesis procedure at the hospital to collect the PBMCs or Peripheral Blood Mononuclear Cells. These act as starting materials for preparation of Dendritic Cells in lab.
3
APCEDEN® Preparation
The manufacturing process lasts for 8 days. Six doses are made simultaneously each having 5-7 million Dendritic cells (DCs).
5
APCEDEN® Personalised Immunotherapy shipped to the Cancer Patient
Once manufactured, the doses are cryopreserved and shipped in temperature controlled conditions via APAC's specialised logistics team to the clinical site for administration as per the cancer patient's dosage schedule.
4
Quality Control
At each step there are stringent check points before either the bag or the tumor tissue enters the processing department. Similarly the prepared doses are subjected to US FDA approved quality checks before it is handed over to the logistics department for dispatch.
- PROCESS
Our Immunotherapy Process
1
Tumor Cell Collection
The patient undergoes surgery or biopsy to collect fresh tumor tissue, stored in a special transport medium and sent to APAC Biotech’s central lab.
2
Leukapheresis Collection
Peripheral Blood Mononuclear Cells (PBMCs) are collected from the patient through a Leukapheresis procedure, and transported to our lab for further processing.
3
APCEDEN® Preparation
Over an 8-day manufacturing process, six doses of Dendritic Cells (DCs) are created, with end-to-end logistics support for transport and delivery.
5
Shipping & Administration
The final doses are cryopreserved and shipped in temperature-controlled conditions to the clinical site for infusion as per the patient’s schedule (every 2 weeks over 3 months).
4
Quality Control
Each step undergoes rigorous quality checks, including FDA-approved testing, to ensure the highest standards before shipping to the clinical site.
Patent/IP
Download our detailed Patent/IP documentation
- WHY CHOOSE US
Why Choose Us for Your Cancer Treatment?
Personalized Expertise
We specialize in tailored cancer treatments, designed specifically for each patient’s needs.
End-to-End Support
From tumor collection to shipping final doses, we handle every step with precision and care.
FDA-Approved Quality
Our treatments undergo rigorous testing to ensure the highest standards of safety and effectiveness.
Reliable Delivery
We provide temperature-controlled shipping and timely administration to ensure your treatment is delivered safely and on schedule.
- VISION
Founder & CEO's Vision
Mr. Arun Mehra is a renowned entrepreneur and visionary with an experience of over 4 decades in various business fields. As the driving force behind Apac Biotech, a pioneering immunotherapy company, Mr. Mehra has been instrumental in developing innovative solutions to combat this devastating disease. With a deep-rooted passion for healthcare and a keen understanding of the challenges faced by cancer patients, Mr. Mehra founded Apac Biotech with a singular goal: to provide affordable and effective immunotherapy treatments to patients across India.
Recognizing the immense potential of immunotherapy in the fight against cancer, he has spearheaded the development of cutting-edge therapies that harness the body's own immune system to target and destroy cancer cells. Mr. Mehra's vision for Apac Biotech extends beyond just developing innovative treatments. He is committed to making these therapies accessible to a wider population, particularly those who may otherwise struggle to afford expensive treatments. By focusing on cost-effective solutions, Apac Biotech aims to democratize access to immunotherapy and improve the quality of life for countless cancer patients.
- TESIMONIALS
Our Patient's Stories
I landed in India at Apac Biotech with a lot of hope to treat my terminal illness and I found I made the right decision. It has truly given me my life back. I was so sick it is indeed a miracle to me. I have gone from barely being able to walk a block to being able to walk for miles everyday, and took up yoga while here in India. Best part is APCEDEN® doesn't have side effects like chemo, radiation etc!
Christopher Mccue
This is a kind of rebirth for me and there are no signs of recurrence. My earlier lifestyle could perhaps have triggered the disease, but I am a changed man. I had earlier been to some hospitals in Mumbai and they suggested surgery. But the mass was so deep inside that a part of my tongue had to be extracted. I came to Ruby Hall when I thought it was already too late. Now I just want to complete my bucket list in this new life.
Rakesh Pitawala
I am 77 yrs old male and was diagnosed with Ca Prostate in Aug 2009. I was feeling very weak and was not in condition to walk properly because of pain in the legs. I was advised for Dendritic Cell Therapy in May 2012. At the time of my DC therapy my PSA was 45 ng/ml and my disease was very unstable. I was given 6 doses of Apceden. After 5 doses my PSA level came down to 24 ng/ml. Now my disease is very stable and I have immensely benefitted by Dendritic cell therapy.
77 yr, Male
- CONTACT
